Amplify Therapeutics

Lysosomal Therapeutics

This biotechnology firm develops small-molecule therapies for patients with neurodegenerative conditions such as Parkinson's disease and other lysosomal storage disorders.

Mair Therapeutics

This biotechnology company develops small-molecule therapeutics targeting lysosomal ion channels for patients with neurodegenerative conditions such as Parkinson’s disease.

Mair Therapeutics

This biotechnology company develops small-molecule therapies targeting lysosomal ion channels to treat neurodegenerative disorders such as Parkinson's disease for patients and healthcare institutions.

Vanqua Bio

This biopharmaceutical firm develops small-molecule therapies for patients with neurodegenerative conditions including Parkinson's disease, Alzheimer's and Gaucher disease.

Nitrase Therapeutics

This biopharmaceutical company develops enzyme-targeting therapies for patients with Parkinson's disease, cancer, and other age-related conditions.

Spur Therapeutics

This company develops adeno-associated virus gene therapies to treat chronic conditions including Gaucher disease and Parkinson's disease for patients with inherited genetic disorders.

Parkinnova Therapeutics

This company develops small molecule phosphodiesterase inhibitors to replenish dopamine and slow disease progression for patients with Parkinson’s disease.

Amplifier Therapeutics

This biopharmaceutical company develops AMP-activated protein kinase activator compounds to treat patients with cardiometabolic, kidney and other age-related diseases.